The controversy over patenting genes took a new twist in February, when a
patients group got in on the act. PXE International patented methods of treating
the debilitating genetic disease PXE based on the MRP6 gene. Mutations
in MRP6 are to blame for the disease. The group hopes that owning the
gene will allow it to accelerate research, control licence fees and prevent turf
wars between scientists.
More from New Ä¢¹½Ö±²¥
Explore the latest news, articles and features
Technology
Laser weapons have come of age and are making their way to the battlefield
News
Society
Timeline: The biggest breakthroughs of the past 70 years
Features
Space
We now know how radiation destroys electronics devices
News
Society
“The gut microbiome will become part of every person’s medical record”
Features
Popular articles
Trending New Ä¢¹½Ö±²¥ articles